Articles with public access mandates - Keith Stockerl-GoldsteinLearn more
Not available anywhere: 1
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell …
SW Choi, T Braun, L Chang, JLM Ferrara, A Pawarode, JM Magenau, ...
The lancet oncology 15 (1), 87-95, 2014
Mandates: US National Institutes of Health
Available somewhere: 74
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
Mandates: US National Institutes of Health, Fonds de recherche du Québec - Santé
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy
JG Lohr, P Stojanov, SL Carter, P Cruz-Gordillo, MS Lawrence, D Auclair, ...
Cancer cell 25 (1), 91-101, 2014
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ...
New England Journal of Medicine 375 (21), 2023-2036, 2016
Mandates: US National Institutes of Health
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma
AJ Jakubowiak, D Dytfeld, KA Griffith, D Lebovic, DH Vesole, S Jagannath, ...
Blood, The Journal of the American Society of Hematology 120 (9), 1801-1809, 2012
Mandates: US National Institutes of Health
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
GL Uy, MP Rettig, IH Motabi, K McFarland, KM Trinkaus, LM Hladnik, ...
Blood, The Journal of the American Society of Hematology 119 (17), 3917-3924, 2012
Mandates: US National Institutes of Health
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ...
Annals of oncology 32 (6), 787-800, 2021
Mandates: US National Institutes of Health, Fonds de recherche du Québec - Santé
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
Mandates: US National Institutes of Health, US Assistant Secretary for Preparedness …
Maintenance therapy with decitabine after allogeneic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
I Pusic, J Choi, MA Fiala, F Gao, M Holt, AF Cashen, R Vij, CN Abboud, ...
Biology of Blood and Marrow Transplantation 21 (10), 1761-1769, 2015
Mandates: US National Institutes of Health
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
TA Fehniger, GL Uy, K Trinkaus, AD Nelson, J Demland, CN Abboud, ...
Blood, The Journal of the American Society of Hematology 117 (6), 1828-1833, 2011
Mandates: US National Institutes of Health
Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience
AC Wolff, AL Blackford, K Visvanathan, HS Rugo, B Moy, LJ Goldstein, ...
Journal of clinical oncology 33 (4), 340-348, 2015
Mandates: US National Institutes of Health, Susan G. Komen
Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation
JP Smeltzer, AF Cashen, Q Zhang, A Homb, F Dehdashti, CN Abboud, ...
Biology of Blood and Marrow Transplantation 17 (11), 1646-1652, 2011
Mandates: US National Institutes of Health
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
A Rashidi, M Hamadani, MJ Zhang, HL Wang, H Abdel-Azim, M Aljurf, ...
Blood advances 3 (12), 1826-1836, 2019
Mandates: US Department of Defense, US National Institutes of Health, Patient-Centered …
A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sezary syndrome
PA Wu, YH Kim, PW Lavori, RT Hoppe, KE Stockerl-Goldstein
Biology of Blood and Marrow Transplantation 15 (8), 982-990, 2009
Mandates: US National Institutes of Health
Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia
MM Berrien-Elliott, AF Cashen, CC Cubitt, CC Neal, P Wong, JA Wagner, ...
Cancer discovery 10 (12), 1854-1871, 2020
Mandates: US National Institutes of Health, V Foundation, USA
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow …
P Armand, HT Kim, MJ Zhang, WS Perez, PS Dal Cin, TR Klumpp, ...
Biology of Blood and Marrow Transplantation 18 (2), 280-288, 2012
Mandates: US National Institutes of Health
NCCN guidelines insights: multiple myeloma, version 3.2016
KC Anderson, M Alsina, D Atanackovic, JS Biermann, JC Chandler, ...
Journal of the National Comprehensive Cancer Network 14 (4), 389-400, 2016
Mandates: US National Institutes of Health
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy
MM Berrien-Elliott, M Becker-Hapak, AF Cashen, M Jacobs, P Wong, ...
Blood, The Journal of the American Society of Hematology 139 (8), 1177-1183, 2022
Mandates: US National Institutes of Health, V Foundation, USA
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft
MA Schroeder, MP Rettig, S Lopez, S Christ, M Fiala, W Eades, FA Mir, ...
Blood, The Journal of the American Society of Hematology 129 (19), 2680-2692, 2017
Mandates: US National Institutes of Health
Multiple myeloma, version 2.2016
KC Anderson, M Alsina, D Atanackovic, JS Biermann, JC Chandler, ...
Journal of the National Comprehensive Cancer Network 13 (11), 1398-1435, 2015
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program